These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36996486)

  • 1. Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.
    Han S; Quach T; Hu L; Lim SF; Zheng D; Leong NJ; Sharma G; Bonner D; Simpson JS; Trevaskis NL; Porter CJH
    Mol Pharm; 2023 May; 20(5):2675-2685. PubMed ID: 36996486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Conjugation Position and Linker Chemistry on the Lymphatic Transport of a Series of Glyceride and Phospholipid Mimetic Prodrugs.
    Han S; Quach T; Hu L; Lim SF; Gracia G; Trevaskis NL; Simpson JS; Porter CJH
    J Pharm Sci; 2021 Jan; 110(1):489-499. PubMed ID: 33069711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic Transport and Lymphocyte Targeting of a Triglyceride Mimetic Prodrug Is Enhanced in a Large Animal Model: Studies in Greyhound Dogs.
    Han S; Hu L; Gracia ; Quach T; Simpson JS; Edwards GA; Trevaskis NL; Porter CJ
    Mol Pharm; 2016 Oct; 13(10):3351-3361. PubMed ID: 27608166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug.
    Han S; Hu L; Quach T; Simpson JS; Trevaskis NL; Porter CJ
    Pharm Res; 2015 May; 32(5):1830-44. PubMed ID: 25446770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice.
    Kochappan R; Cao E; Han S; Hu L; Quach T; Senyschyn D; Ferreira VI; Lee G; Leong N; Sharma G; Lim SF; Nowell CJ; Chen Z; von Andrian UH; Bonner D; Mintern JD; Simpson JS; Trevaskis NL; Porter CJH
    J Control Release; 2021 Apr; 332():636-651. PubMed ID: 33609620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive Triglyceride Turnover into the Mesenteric Lymph Is Unable to Support Efficient Lymphatic Transport of a Biomimetic Triglyceride Prodrug.
    Han S; Hu L; Quach T; Simpson JS; Trevaskis NL; Porter CJH
    J Pharm Sci; 2016 Feb; 105(2):786-796. PubMed ID: 26540595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism.
    Wang X; Zhang C; Han N; Luo J; Zhang S; Wang C; Jia Z; Du S
    Drug Deliv; 2021 Dec; 28(1):1664-1672. PubMed ID: 34338567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of lipophilic ester prodrugs of dolutegravir for intestinal lymphatic transport.
    Chu Y; Wong A; Chen H; Ji L; Qin C; Feng W; Stocks MJ; Gershkovich P
    Eur J Pharm Biopharm; 2023 Oct; 191():90-102. PubMed ID: 37634824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport.
    Quach T; Hu L; Han S; Lim SF; Senyschyn D; Yadav P; Trevaksis NL; Simpson JS; Porter CJH
    Front Pharmacol; 2022; 13():879660. PubMed ID: 35496278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability.
    Hu L; Quach T; Han S; Lim SF; Yadav P; Senyschyn D; Trevaskis NL; Simpson JS; Porter CJ
    Angew Chem Int Ed Engl; 2016 Oct; 55(44):13700-13705. PubMed ID: 27482655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system.
    Lee JB; Zgair A; Malec J; Kim TH; Kim MG; Ali J; Qin C; Feng W; Chiang M; Gao X; Voronin G; Garces AE; Lau CL; Chan TH; Hume A; McIntosh TM; Soukarieh F; Al-Hayali M; Cipolla E; Collins HM; Heery DM; Shin BS; Yoo SD; Kagan L; Stocks MJ; Bradshaw TD; Fischer PM; Gershkovich P
    J Control Release; 2018 Sep; 286():10-19. PubMed ID: 30016732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes.
    Chu Y; Qin C; Feng W; Sheriston C; Jane Khor Y; Medrano-Padial C; Watson BE; Chan T; Ling B; Stocks MJ; Fischer PM; Gershkovich P
    Int J Pharm; 2021 Jun; 602():120621. PubMed ID: 33892057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the Intestine.
    Xie Y; Lu Z; Styles IK; Reddiar SB; Phillips ARJ; Windsor JA; Porter CJH; Han S; Trevaskis NL
    J Pharm Sci; 2024 Aug; 113(8):2342-2351. PubMed ID: 38582284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Intestinal Digestion and On Site Tumor-Bioactivation are the Two Important Determinants for Chylomicron-Mediated Lymph-Targeting Triglyceride-Mimetic Docetaxel Oral Prodrugs.
    Tian C; Guo J; Wang G; Sun B; Na K; Zhang X; Xu Z; Cheng M; He Z; Sun J
    Adv Sci (Weinh); 2019 Dec; 6(24):1901810. PubMed ID: 31871861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach.
    Qin C; Chu Y; Feng W; Fromont C; He S; Ali J; Lee JB; Zgair A; Berton M; Bettonte S; Liu R; Yang L; Monmaturapoj T; Medrano-Padial C; Ugalde AAR; Vetrugno D; Ee SY; Sheriston C; Wu Y; Stocks MJ; Fischer PM; Gershkovich P
    J Control Release; 2021 Jan; 329():1077-1089. PubMed ID: 33091528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing Oral Performance of Paclitaxel Lipid-Mimic Prodrug via Modulating Type of Fatty Acids.
    Miao YF; Ye Q; Zhang MY; Gao L; Wang XY; Zhong WX; Wang ZX; He ZG; Tian CT; Sun J
    Adv Healthc Mater; 2023 Jul; 12(19):e2203118. PubMed ID: 36929289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long chain triglyceride-lipid formulation promotes the oral absorption of the lipidic prodrugs through coincident intestinal behaviors.
    Tian CT; Guo JJ; Miao YF; Wang HL; Ye Q; Guo CL; Zhang MY; He ZG; Sun J
    Eur J Pharm Biopharm; 2022 Jul; 176():122-132. PubMed ID: 35643367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport.
    Trevaskis NL; Hu L; Caliph SM; Han S; Porter CJ
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25866901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.